KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ionis Pharmaceuticals (IONS) EBT Margin (2016 - 2025)

Historic EBT Margin for Ionis Pharmaceuticals (IONS) over the last 17 years, with Q3 2025 value amounting to 81.93%.

  • Ionis Pharmaceuticals' EBT Margin rose 257600.0% to 81.93% in Q3 2025 from the same period last year, while for Sep 2025 it was 32.71%, marking a year-over-year increase of 116900.0%. This contributed to the annual value of 65.34% for FY2024, which is 228400.0% down from last year.
  • According to the latest figures from Q3 2025, Ionis Pharmaceuticals' EBT Margin is 81.93%, which was up 257600.0% from 44.44% recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' EBT Margin registered a high of 50.93% during Q4 2021, and its lowest value of 119.44% during Q1 2024.
  • Moreover, its 5-year median value for EBT Margin was 62.94% (2021), whereas its average is 53.51%.
  • Per our database at Business Quant, Ionis Pharmaceuticals' EBT Margin skyrocketed by 2088400bps in 2021 and then crashed by -804500bps in 2022.
  • Over the past 5 years, Ionis Pharmaceuticals' EBT Margin (Quarter) stood at 50.93% in 2021, then crashed by -158bps to 29.52% in 2022, then skyrocketed by 96bps to 1.08% in 2023, then plummeted by -4295bps to 47.53% in 2024, then tumbled by -72bps to 81.93% in 2025.
  • Its last three reported values are 81.93% in Q3 2025, 44.44% for Q2 2025, and 111.56% during Q1 2025.